The Big Apple has taken another bite out of Cambridge UK biotech with a near-$44 million acquisition of Abzena by a newly-formed New York enterprise.
Read the full article here: https://www.businessweekly.co.uk/news/biomedtech/new-york-venture-takes-abzena-44m-cap-great-week-babraham
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557